Go to Top

Home

News

Idarucizumab Approved by Health Canada as Dabigatran Antidote

Idarucizumab  is now available as an antidote for dabigatran. Please refer to the highlighted clinical guides, clinical tools, and resources below for further information.  Please note, that Thrombosis Canada in partnership with Think Research has developed a Bleed Management patient order set. Clinical Guides Dabigatran New/Novel Oral Anticoagulants (NOACs): Management of Bleeding Clinical Tools We have also updated our Perioperative Anticoagulant

Read More

REEL Talks: Real Experience – Expert Learning

REEL Talks is a series of short videos created in partnership with Thrombosis Canada and leading experts.  The format of each video is designed to create an informative and thought provoking experience for the viewer, focusing on important messages in stroke prevention.   Stroke Prevention Watch the videos in English and French here. Bleed Management Watch the videos in English

Read More